EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma

por Randolph, Matthew E., Cleary, Megan M., Bajwa, Zia, Svalina, Matthew N., Young, Michael C., Mansoor, Atiya, Kaur, Pali, Bult, Carol J., Goros, Martin W., Michalek, Joel E., Xiang, Sunny, Keck, James, Krasnoperov, Valery, Gill, Parkash, Keller, Charles
Publicado 2017

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

por Bharathy, Narendra, Svalina, Matthew N., Settelmeyer, Teagan P., Cleary, Megan M., Berlow, Noah E., Airhart, Susan D., Xiang, Sunny, Keck, James, Hayden, James B., Shern, Jack F., Mansoor, Atiya, Lathara, Melvin, Srinivasa, Ganapati, Langenau, David M., Keller, Charles
Publicado 2017